"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have.
written reports, including local media accounts, professional medical papers and internal emails were also examined..
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".